Clinical Trial Update: Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and immunogenicity of meningococcal and pneumococcal vaccination in adults living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Meningococcal Infections
• Pneumococcal Infections

Snippet

Sponsor: Thomas Benfield | Conditions: Hiv, Meningococcal Infections | Phase 4 | Status: RECRUITING